HomeMGNX • NASDAQ
MacroGenics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 19.35M | 80.53% |
Operating expense | 27.81M | 121.42% |
Net income | -15.42M | 66.53% |
Net profit margin | -79.68 | 81.46% |
Earnings per share | -0.82 | -9.07% |
EBITDA | -50.78M | -7.02% |
Effective tax rate | -6.52% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.67M | -12.24% |
Total assets | 261.66M | -12.32% |
Total liabilities | 145.60M | -0.14% |
Total equity | 116.06M | — |
Shares outstanding | 63.09M | — |
Price to book | 0.66 | — |
Return on assets | -50.21% | — |
Return on capital | -85.86% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -15.42M | 66.53% |
Cash from operations | -38.41M | -36.99% |
Cash from investing | 41.47M | 6.81% |
Cash from financing | 155.00K | -43.22% |
Net change in cash | 3.22M | -70.93% |
Free cash flow | -18.21M | -164.50% |
Previous close
$1.22
Day range
$1.18 - $1.25
Year range
$1.17 - $19.54
Market cap
76.97M USD
Avg Volume
696.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2000
Headquarters
Website
Employees
341